Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules
- 1 January 1998
- journal article
- review article
- Published by Taylor & Francis in Climacteric
- Vol. 1 (1) , 12-17
- https://doi.org/10.3109/13697139809080676
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Clinical Trials Report: Oncologic, Endocrine & Metabolic: Clinical trials in progress with hormone replacement therapyExpert Opinion on Investigational Drugs, 1996
- Recommendations for the registration of new chemical entities used in the prevention and treatment of osteoporosisCalcified Tissue International, 1995
- Effects of estrogens on lipoprotein metabolism and cardiovascular disease in womenAtherosclerosis, 1994
- A Controlled Trial of Intravaginal Estriol in Postmenopausal Women with Recurrent Urinary Tract InfectionsNew England Journal of Medicine, 1993
- NIH Unveils Plan for Women's Health ProjectScience, 1991
- Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinenceInternational Urogynecology Journal, 1990
- Occurrence, nature and treatment of urinary incontinence in a 70-year-old female populationMaturitas, 1985
- Urethral Sphincteric Insufficiency in Postmenopausal Females: Treatment with Phenylpropanolamine and Estriol Separately and in CombinationUrologia Internationalis, 1984